LabCorp announced the launch of the informaSeq Prenatal Test, a non-invasive prenatal screening assay that can assess for multiple fetal chromosomal aneuploidies, or abnormalities in the number of chromosomes from a single maternal blood draw.

The test also offers screenings for additional common sex-related aneuploidies. It is offered through Integrated Genetics, part of the LabCorp Specialty Testing Group. The informaSeq Prenatal Test utilizes Illumina sequencing technology to generate test data, which offers high sensitivity and specificity rates even in samples containing less fetal DNA fragments.

RELATED: Noninvasive First-Trimester Screen Drops CVS/Amnio Rates

For more information call (800) 845-6167 or visit